Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,853 | 152 | 95.2% |
| Education | $143.17 | 8 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $336.32 | 22 | $0 (2020) |
| Amgen Inc. | $287.85 | 18 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $231.78 | 8 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $200.16 | 7 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $178.48 | 10 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $177.09 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $148.80 | 8 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $145.42 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $141.27 | 8 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $124.23 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $847.80 | 39 | Boehringer Ingelheim Pharmaceuticals, Inc. ($118.51) |
| 2023 | $415.59 | 24 | OPKO Pharmaceuticals, LLC ($55.50) |
| 2022 | $200.33 | 11 | Horizon Therapeutics plc ($38.07) |
| 2021 | $280.37 | 17 | AKEBIA THERAPEUTICS INC ($116.63) |
| 2020 | $188.47 | 6 | Otsuka America Pharmaceutical, Inc. ($95.01) |
| 2019 | $231.40 | 14 | Relypsa, Inc. ($107.92) |
| 2018 | $333.72 | 23 | Relypsa, Inc. ($141.00) |
| 2017 | $498.20 | 26 | Keryx Biopharmaceuticals, Inc. ($231.78) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Catheter Lock Solution | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Nephrology | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/26/2024 | Fresenius USA Marketing, Inc. | CRIT-LINE (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: System, Hemodialysis, Access Recirculation Monitoring | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.25 | General |
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Nephrology | ||||||
| 10/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Nephrology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/14/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $29.20 | General |
| 10/11/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $62.36 | General |
| Category: Endovascular | ||||||
| 09/12/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $15.33 | General |
| Category: NEPHROLOGY | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiology | ||||||
| 08/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Nephrology | ||||||
| 08/06/2024 | Fresenius USA Marketing, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $54.31 | General |
| Category: Nephrology | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.41 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,129 | 2,421 | $558,175 | $267,501 |
| 2022 | 15 | 1,188 | 2,812 | $628,940 | $328,778 |
| 2021 | 13 | 1,406 | 3,469 | $674,600 | $402,166 |
| 2020 | 14 | 1,416 | 3,273 | $707,090 | $364,974 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 54 | 279 | $156,150 | $77,012 | 49.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 248 | 914 | $109,680 | $56,988 | 52.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 28 | 163 | $89,650 | $38,142 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 371 | $64,865 | $24,899 | 38.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 38 | 74 | $34,150 | $16,974 | 49.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 103 | 110 | $29,700 | $15,037 | 50.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 92 | $16,560 | $9,443 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 171 | $18,810 | $9,374 | 49.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 72 | 128 | $16,000 | $7,205 | 45.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 76 | $12,160 | $7,130 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,400 | $2,522 | 57.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 11 | 11 | $4,250 | $1,730 | 40.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,800 | $1,045 | 58.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 60 | 330 | $174,250 | $93,251 | 53.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 289 | 1,046 | $115,560 | $58,407 | 50.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 32 | 228 | $114,150 | $55,411 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 291 | 450 | $65,340 | $33,888 | 51.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 47 | 115 | $48,050 | $26,884 | 56.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 109 | 114 | $29,960 | $17,719 | 59.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 72 | 93 | $16,740 | $9,869 | 59.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 106 | $16,040 | $8,524 | 53.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 61 | 121 | $15,125 | $6,952 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $7,780 | $4,776 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 88 | $9,080 | $4,763 | 52.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 19 | 22 | $7,700 | $3,532 | 45.9% |
About Dr. Sayed Osama, M.D
Dr. Sayed Osama, M.D is a Specialist healthcare provider based in Flint, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467442038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Osama, M.D has received a total of $2,996 in payments from pharmaceutical and medical device companies, with $847.80 received in 2024. These payments were reported across 160 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,853).
As a Medicare-enrolled provider, Osama has provided services to 5,139 Medicare beneficiaries, totaling 11,975 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Flint, MI
- Active Since 10/25/2005
- Last Updated 09/26/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1467442038
Products in Payments
- Veltassa (Drug) $401.05
- Auryxia (Drug) $367.96
- KRYSTEXXA (Biological) $184.08
- JYNARQUE (Drug) $155.58
- JARDIANCE (Drug) $148.80
- RAYALDEE (Drug) $129.57
- TARPEYO (Drug) $124.23
- Parsabiv (Biological) $123.20
- Kerendia (Drug) $119.85
- Velphoro (Drug) $73.39
- LUPKYNIS (Drug) $68.66
- PARADISE RENAL DENERVATION SYSTEM (Device) $62.36
- LOKELMA (Drug) $55.49
- NXSTAGE SYSTEM ONE (Device) $54.31
- TAVNEOS (Drug) $53.47
- SAMSCA (Drug) $44.58
- BENLYSTA (Biological) $42.90
- FARXIGA (Drug) $38.88
- KRYSTEXXA (Drug) $37.00
- FABRAZYME (Biological) $36.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Flint
Randy Hicks, Md, MD
Specialist — Payments: $104,512
Ethiraj Raj, Md, MD
Specialist — Payments: $10,185
Mr. Mohamadali Amlani, M.d, M.D
Specialist — Payments: $8,534
Dr. Ahmad Kaddurah, Md, MD
Specialist — Payments: $7,359
Nestor Tomycz, M.d, M.D
Specialist — Payments: $7,232
Dr. David Strahle, Md, MD
Specialist — Payments: $2,830